TRACON Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Summary
Global Market Direct’s pharmaceuticals report, “TRACON Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the TRACON Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, TRACON Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from TRACON Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
Current R&D Portfolio of TRACON Pharmaceuticals, Inc.; TRACON Pharmaceuticals, Inc. - Key Therapeutics; TRACON Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; TRACON Pharmaceuticals, Inc. - News; TRACON Pharmaceuticals, Inc. - Latest Updates; TRACON Pharmaceuticals, Inc. - Pipeline; TRACON Pharmaceuticals, Inc. - Discontinued/Dormant Projects
Summary
Global Market Direct’s pharmaceuticals report, “TRACON Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the TRACON Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, TRACON Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from TRACON Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- TRACON Pharmaceuticals, Inc. - Brief TRACON Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TRACON Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of TRACON Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the TRACON Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
- Evaluate TRACON Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of TRACON Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the TRACON Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with TRACON Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of TRACON Pharmaceuticals, Inc. and identify potential opportunities in those areas.
Current R&D Portfolio of TRACON Pharmaceuticals, Inc.; TRACON Pharmaceuticals, Inc. - Key Therapeutics; TRACON Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; TRACON Pharmaceuticals, Inc. - News; TRACON Pharmaceuticals, Inc. - Latest Updates; TRACON Pharmaceuticals, Inc. - Pipeline; TRACON Pharmaceuticals, Inc. - Discontinued/Dormant Projects
TRACON Pharmaceuticals, Inc. Snapshot
TRACON Pharmaceuticals, Inc. Overview
Key Information
Key Facts
TRACON Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
TRACON Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Pipeline Products Glance
TRACON Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Drug Profiles
TRC102 + Alimta
Product Description
Mechanism of Action
R&D Progress
TRC102 + Fludara
Product Description
Mechanism of Action
R&D Progress
TRC102 + Temodar
Product Description
Mechanism of Action
R&D Progress
TRC105
Product Description
Mechanism of Action
R&D Progress
TRC105 + Avastin
Product Description
Mechanism of Action
R&D Progress
TRC105 + Nexavar
Product Description
Mechanism of Action
R&D Progress
TRC105 + Xeloda
Product Description
Mechanism of Action
R&D Progress
TRACON Pharmaceuticals, Inc. – Pipeline Analysis
TRACON Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
TRACON Pharmaceuticals, Inc. – Pipeline Products By Target
TRACON Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
TRACON Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action
TRACON Pharmaceuticals, Inc. – Recent Pipeline Updates
TRACON Pharmaceuticals, Inc. - Dormant Projects
TRACON Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
TRACON Pharmaceuticals, Inc., Deals Summary
TRACON Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
TRACON Pharma Secures $14 Million In Venture Financing
TRACON Pharma Secures $0.75 Million In Venture Financing
Partnerships
TRACON Enters Into Co-Development Agreement With NCI
Licensing Agreements
Micromet Enters Into License Agreement Agreement With TRACON Pharma
Case Western Reserve University Enters Into Licensing TRACON Pharma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
TRACON Pharmaceuticals, Inc., Key Information
TRACON Pharmaceuticals, Inc., Key Facts
TRACON Pharmaceuticals, Inc. – Pipeline by Indication, 2012
TRACON Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2012
TRACON Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Combination Treatment Modalities in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Phase II, 2012
TRACON Pharmaceuticals, Inc. – Phase I, 2012
TRACON Pharmaceuticals, Inc. – Pre-Clinical, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2012
TRACON Pharmaceuticals, Inc. - Pipeline By Target, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2012
TRACON Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action, 2012
TRACON Pharmaceuticals, Inc. – Recent Pipeline Updates, 2012
TRACON Pharmaceuticals, Inc. - Dormant Developmental Projects,2012
TRACON Pharmaceuticals, Inc., Deals Summary
TRACON Pharma Secures $14 Million In Venture Financing
TRACON Pharma Secures $0.75 Million In Venture Financing
TRACON Enters Into Co-Development Agreement With NCI
Micromet Enters Into License Agreement Agreement With TRACON Pharma
Case Western Reserve University Enters Into Licensing TRACON Pharma
LIST OF FIGURES
TRACON Pharmaceuticals, Inc. – Pipeline by Indication, 2012
TRACON Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2012
TRACON Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Combination Treatment Modalities in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2012
TRACON Pharmaceuticals, Inc. - Pipeline By Target, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2012
TRACON Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action, 2012
TRACON Pharmaceuticals, Inc. Overview
Key Information
Key Facts
TRACON Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
TRACON Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Pipeline Products Glance
TRACON Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
TRACON Pharmaceuticals, Inc. – Drug Profiles
TRC102 + Alimta
Product Description
Mechanism of Action
R&D Progress
TRC102 + Fludara
Product Description
Mechanism of Action
R&D Progress
TRC102 + Temodar
Product Description
Mechanism of Action
R&D Progress
TRC105
Product Description
Mechanism of Action
R&D Progress
TRC105 + Avastin
Product Description
Mechanism of Action
R&D Progress
TRC105 + Nexavar
Product Description
Mechanism of Action
R&D Progress
TRC105 + Xeloda
Product Description
Mechanism of Action
R&D Progress
TRACON Pharmaceuticals, Inc. – Pipeline Analysis
TRACON Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
TRACON Pharmaceuticals, Inc. – Pipeline Products By Target
TRACON Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
TRACON Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action
TRACON Pharmaceuticals, Inc. – Recent Pipeline Updates
TRACON Pharmaceuticals, Inc. - Dormant Projects
TRACON Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
TRACON Pharmaceuticals, Inc., Deals Summary
TRACON Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
TRACON Pharma Secures $14 Million In Venture Financing
TRACON Pharma Secures $0.75 Million In Venture Financing
Partnerships
TRACON Enters Into Co-Development Agreement With NCI
Licensing Agreements
Micromet Enters Into License Agreement Agreement With TRACON Pharma
Case Western Reserve University Enters Into Licensing TRACON Pharma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
LIST OF TABLES
TRACON Pharmaceuticals, Inc., Key Information
TRACON Pharmaceuticals, Inc., Key Facts
TRACON Pharmaceuticals, Inc. – Pipeline by Indication, 2012
TRACON Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2012
TRACON Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Combination Treatment Modalities in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Phase II, 2012
TRACON Pharmaceuticals, Inc. – Phase I, 2012
TRACON Pharmaceuticals, Inc. – Pre-Clinical, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2012
TRACON Pharmaceuticals, Inc. - Pipeline By Target, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2012
TRACON Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action, 2012
TRACON Pharmaceuticals, Inc. – Recent Pipeline Updates, 2012
TRACON Pharmaceuticals, Inc. - Dormant Developmental Projects,2012
TRACON Pharmaceuticals, Inc., Deals Summary
TRACON Pharma Secures $14 Million In Venture Financing
TRACON Pharma Secures $0.75 Million In Venture Financing
TRACON Enters Into Co-Development Agreement With NCI
Micromet Enters Into License Agreement Agreement With TRACON Pharma
Case Western Reserve University Enters Into Licensing TRACON Pharma
LIST OF FIGURES
TRACON Pharmaceuticals, Inc. – Pipeline by Indication, 2012
TRACON Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2012
TRACON Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Combination Treatment Modalities in Pipeline, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2012
TRACON Pharmaceuticals, Inc. - Pipeline By Target, 2012
TRACON Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2012
TRACON Pharmaceuticals, Inc. - Pipeline Products By Mechanism of Action, 2012
